Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Geisen

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|August 1, 2002
The oncogenic activity of cyclin E is not confined to Cdk2 activation alone but relies on several other, distinct functions of the proteinChristoph Geisen, Tarik Moroy
The International Journal of Biochemistry & Cell Biology|May 19, 2004
Cyclin ETarik Möröy, Christoph Geisen
Oncogene|March 19, 2003
Loss of p27(Kip1) cooperates with cyclin E in T-cell lymphomagenesisChristoph Geisen, Holger Karsunky, Raif Yücel, et al.
Cancer Letters|April 23, 2003
Yaf2 inhibits Myc biological functionBritta Mädge, Christoph Geisen, Tarik Möröy, et al.
The EMBO Journal|November 13, 2004
Interaction between human MCM7 and Rad17 proteins is required for replication checkpoint signalingCheng-Chung Tsao, Christoph Geisen, Robert T Abraham
The Journal of Biological Chemistry|May 16, 2003
Identification of a novel Krüppel-associated box domain protein, Krim-1, that interacts with c-Myc and inhibits its oncogenic activityHanjo Hennemann, Lothar Vassen, Christoph Geisen, et al.
Clinical Laboratory|February 9, 2002
Comparison of three dsDNA-ELISAs with regard to their efficiency in the diagnosis of systemic lupus erythematosusMarkus Linnemann, Christoph Geisen, Sabine Menn, et al.
Developmental Cell|March 12, 2014
DRE-1/FBXO11-dependent degradation of BLMP-1/BLIMP-1 governs C. elegans developmental timing and maturationMoritz Horn, Christoph Geisen, Lukas Cermak, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
New indene-derivatives with anti-proliferative propertiesIoanna-Maria Karaguni, Karl-Heinz Glüsenkamp, Anette Langerak, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2008
Kinase requirements in human cells: III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screenArchana Bommi-Reddy, Ingrid Almeciga, Jacqueline Sawyer, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|August 1, 2002
The oncogenic activity of cyclin E is not confined to Cdk2 activation alone but relies on several other, distinct functions of the proteinChristoph Geisen, Tarik Moroy
The International Journal of Biochemistry & Cell Biology|May 19, 2004
Cyclin ETarik Möröy, Christoph Geisen
Oncogene|March 19, 2003
Loss of p27(Kip1) cooperates with cyclin E in T-cell lymphomagenesisChristoph Geisen, Holger Karsunky, Raif Yücel, et al.
Cancer Letters|April 23, 2003
Yaf2 inhibits Myc biological functionBritta Mädge, Christoph Geisen, Tarik Möröy, et al.
The EMBO Journal|November 13, 2004
Interaction between human MCM7 and Rad17 proteins is required for replication checkpoint signalingCheng-Chung Tsao, Christoph Geisen, Robert T Abraham
The Journal of Biological Chemistry|May 16, 2003
Identification of a novel Krüppel-associated box domain protein, Krim-1, that interacts with c-Myc and inhibits its oncogenic activityHanjo Hennemann, Lothar Vassen, Christoph Geisen, et al.
Clinical Laboratory|February 9, 2002
Comparison of three dsDNA-ELISAs with regard to their efficiency in the diagnosis of systemic lupus erythematosusMarkus Linnemann, Christoph Geisen, Sabine Menn, et al.
Developmental Cell|March 12, 2014
DRE-1/FBXO11-dependent degradation of BLMP-1/BLIMP-1 governs C. elegans developmental timing and maturationMoritz Horn, Christoph Geisen, Lukas Cermak, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
New indene-derivatives with anti-proliferative propertiesIoanna-Maria Karaguni, Karl-Heinz Glüsenkamp, Anette Langerak, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2008
Kinase requirements in human cells: III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screenArchana Bommi-Reddy, Ingrid Almeciga, Jacqueline Sawyer, et al.
Pageof 2